buyModerate cluster of 4
Lisa Zhu bought $501k of VALF
other at Variant Alternative Lending Fund. 20,000 shares at an average of $25.05, traded Nov 20, 2024, filed Nov 21, 2024.
Conviction score
49Value
$501k
20,000 shares
Holdings after
798
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +8RoleOther
- +18Trade size$501k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001839882-24-040522, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 20, 2024 | POpen-market purchase Institutional Class Shares | +20,000 | $25.05 | $501k | 798 | Nov 21, 2024 |
Related signals
Other insiders at Variant Alternative Lending Fund and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | VALFbuy Variant Alternative Lending Fund | Jerald Benjamin Hayes other | $634k 25,000 shares | - | |
| 53Moderate | VALFbuy Variant Alternative Lending Fund | Robert W Elsasser President | $6.3M 250,000 shares | - | |
| 48Moderate | Variant Alternative Lending Fund | Jerald Benjamin Hayes other | $1.3M 50,000 shares | +3% | |
| 70Notable | Variant Alternative Lending Fund | Curtis Neil Fintel Treasurer | $6.3M 250,000 shares | - | |
| 56Moderate | Variant Alternative Lending Fund | Brian Anthony Park other | $2.5M 100,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.